Product Information
MUPIROCIN 2% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2985 per GM under NDC 45802011214. Its NADAC has been published 201 times since Nov 30, 2022.
FDA first approved this application on Nov 7, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802011214
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
MUPIROCINApproval Type
Generic (ANDA)
FDA Application
ANDA065123FDA Approved
11/7/2003
TE Code
AB
On Market Since
10/30/2009
Pharmacological Classes
Price Statistics
The NADAC for MUPIROCIN 2% OINTMENT has been published 201 times since Nov 30, 2022, and over the history we have for it it has risen 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2985 per GM |
|---|---|
| All-time high | $0.3508 (Mar 12, 2025) |
| All-time low | $0.2137 (May 22, 2024) |
| 52-week high | $0.3151 |
| 52-week low | $0.2760 |
| Median price | $0.2762 |
| Average price | $0.2834 |
| Largest weekly change | -18.2% (Apr 17, 2024) |
| Weeks tracked | 201 |
| Tracking since | Nov 30, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Mupirocin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
RNA Synthetase Inhibitor Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUPIROCIN 2% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for MUPIROCIN 2% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2985 per GM (NDC 45802011214), effective Sep 30, 2026.
How has the price of MUPIROCIN 2% OINTMENT changed over time?
Over the history we have for it, the NADAC for MUPIROCIN 2% OINTMENT has risen 9.9%. It has been tracked across 201 weekly CMS publications since Nov 30, 2022.
What are the highest and lowest recorded NADAC prices for MUPIROCIN 2% OINTMENT?
Since Nov 30, 2022, the NADAC for MUPIROCIN 2% OINTMENT has ranged from a low of $0.2137 (May 22, 2024) to a high of $0.3508 (Mar 12, 2025), with a median of $0.2762 per GM.
Are there cheaper alternatives to MUPIROCIN 2% OINTMENT?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MUPIROCIN 2% OINTMENT, is $0.1456 per GM — about 51% below MUPIROCIN 2% OINTMENT.
Who manufactures MUPIROCIN 2% OINTMENT?
MUPIROCIN 2% OINTMENT (NDC 45802011214) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.